Peripheral Blood Stem Cell TransplantationTransplantation, HomologousBone Marrow TransplantationHematopoietic Stem Cell TransplantationGraft vs Host DiseaseHematologic NeoplasmsTransplantation ConditioningHematopoietic Stem Cell MobilizationBone MarrowGranulocyte Colony-Stimulating FactorTransplantation ChimeraGraft SurvivalTransplantation, AutologousBone Marrow CellsBusulfanTissue DonorsAntigens, CD34LeukapheresisWhole-Body IrradiationRecurrenceVidarabineTreatment OutcomeLeukemiaHematopoietic Stem CellsImmunosuppressive AgentsGraft vs Leukemia EffectHistocompatibilityHistocompatibility TestingBone and BonesStem CellsCyclophosphamideAnemia, AplasticSurvival AnalysisCombined Modality TherapyBlood Component RemovalRetrospective StudiesBone Marrow PurgingHematopoiesisStem Cell TransplantationPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMelphalanT-LymphocytesRemission InductionTransplantation, IsogeneicBone Marrow DiseasesMyeloablative AgonistsChronic DiseaseLeukemia, Myeloid, AcuteMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsLeukocyte TransfusionLymphoma, Non-HodgkinLymphocyte DepletionHLA AntigensBlood CellsTime FactorsGraft vs Tumor EffectDisease-Free SurvivalTransplantation ImmunologyRadiation ChimeraMice, Inbred C57BLLymphocyte TransfusionEtoposideAcute DiseaseCord Blood Stem Cell TransplantationCyclosporineMyelodysplastic SyndromesBlood Cell CountLeukemia, MyeloidImmunosuppressionColony-Forming Units AssayGraft vs Host ReactionFlow CytometryCytarabineHematologic DiseasesCytomegalovirus InfectionsBone Marrow ExaminationSurvival RateCell DifferentiationLeukocyte CountNuclear FamilyBone RemodelingImmunophenotypingInfectionChimeraCell SeparationCells, CulturedAntineoplastic Agents, AlkylatingHepatic Veno-Occlusive DiseaseBone Marrow NeoplasmsLiver TransplantationLymphomaGraft RejectionRecombinant ProteinsThiotepaSalvage TherapyAntigens, CDFollow-Up StudiesFatal Outcome